PD 144418 oxalateCAS# 154130-99-1 |
2D Structure
- Irbesartan
Catalog No.:BCC2560
CAS No.:138402-11-6
- Olmesartan
Catalog No.:BCC1819
CAS No.:144689-24-7
- AVE 0991
Catalog No.:BCC4032
CAS No.:304462-19-9
- Tranilast
Catalog No.:BCC2514
CAS No.:53902-12-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 154130-99-1 | SDF | Download SDF |
PubChem ID | 53447361 | Appearance | Powder |
Formula | C20H24N2O5 | M.Wt | 372.42 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 50 mM in DMSO | ||
Chemical Name | 3-(4-methylphenyl)-5-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,2-oxazole;oxalic acid | ||
SMILES | CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C.C(=O)(C(=O)O)O | ||
Standard InChIKey | IWSFHSVGBKPYFN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H22N2O.C2H2O4/c1-3-10-20-11-4-5-16(13-20)18-12-17(19-21-18)15-8-6-14(2)7-9-15;3-1(4)2(5)6/h5-9,12H,3-4,10-11,13H2,1-2H3;(H,3,4)(H,5,6) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | High affinity, selective σ1 ligand (Ki values are 0.08 and 1377 nM for σ1 and σ2 respectively). Displays no significant activity at a wide range of other receptors, ion channels and enzymes. Antagonizes mescaline-induced scratching in mice following i.p. administration. Also attenuates cocaine-induced hyperactivity in mice. |
PD 144418 oxalate Dilution Calculator
PD 144418 oxalate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6851 mL | 13.4257 mL | 26.8514 mL | 53.7028 mL | 67.1285 mL |
5 mM | 0.537 mL | 2.6851 mL | 5.3703 mL | 10.7406 mL | 13.4257 mL |
10 mM | 0.2685 mL | 1.3426 mL | 2.6851 mL | 5.3703 mL | 6.7129 mL |
50 mM | 0.0537 mL | 0.2685 mL | 0.537 mL | 1.0741 mL | 1.3426 mL |
100 mM | 0.0269 mL | 0.1343 mL | 0.2685 mL | 0.537 mL | 0.6713 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Catalog No.:BCC8707
CAS No.:154127-42-1
- 2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Catalog No.:BCC8480
CAS No.:154127-41-0
- ((2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide
Catalog No.:BCC8373
CAS No.:154057-58-6
- 3-(Bromomethyl)-2-cyclopropyl-4-(4'-fluorophenyl)quinoline
Catalog No.:BCC8591
CAS No.:154057-56-4
- Isonormangostin
Catalog No.:BCN1687
CAS No.:15404-80-5
- Fuscaxanthone C
Catalog No.:BCN3885
CAS No.:15404-76-9
- Marimastat
Catalog No.:BCC2118
CAS No.:154039-60-8
- Berberrubine
Catalog No.:BCN2651
CAS No.:15401-69-1
- Ipecoside
Catalog No.:BCN8301
CAS No.:15401-60-2
- Carmustine
Catalog No.:BCC5244
CAS No.:154-93-8
- Bz-Arg-OH
Catalog No.:BCC2856
CAS No.:154-92-7
- Tripelennamine HCl
Catalog No.:BCC4523
CAS No.:154-69-8
- DMAB-anabaseine dihydrochloride
Catalog No.:BCC7301
CAS No.:154149-38-9
- YM 90K hydrochloride
Catalog No.:BCC7455
CAS No.:154164-30-4
- N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine
Catalog No.:BCC9067
CAS No.:154212-61-0
- Clasto-Lactacystin β-lactone
Catalog No.:BCC1224
CAS No.:154226-60-5
- Abiraterone Acotate
Catalog No.:BCN2184
CAS No.:154229-18-2
- Abiraterone
Catalog No.:BCC2259
CAS No.:154229-19-3
- Ampalex
Catalog No.:BCC1359
CAS No.:154235-83-3
- CB-5083
Catalog No.:BCC6528
CAS No.:1542705-92-9
- Echistatin, α1 isoform
Catalog No.:BCC5988
CAS No.:154303-05-6
- Capecitabine
Catalog No.:BCN2168
CAS No.:154361-50-9
- Methyl 3-O-feruloylquinate
Catalog No.:BCN3403
CAS No.:154418-15-2
- 5,5'-Dimethoxylariciresinol 4-O-glucoside
Catalog No.:BCN1556
CAS No.:154418-16-3
Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418.[Pubmed:25100754]
J Pharmacol Exp Ther. 2014 Oct;351(1):153-63.
Psychostimulant effects of cocaine are mediated partly by agonist actions at sigma-1 (sigma1) receptors. Selective sigma1 receptor antagonists attenuate these effects and provide a potential avenue for pharmacotherapy. However, the selective and high affinity sigma1 antagonist PD144418 (1,2,3,6-tetrahydro-5-[3-(4-methylphenyl)-5-isoxazolyl]-1-propylpyridine) has been reported not to inhibit cocaine-induced hyperactivity. To address this apparent paradox, we evaluated aspects of PD144418 binding in vitro, investigated sigma1 receptor and dopamine transporter (DAT) occupancy in vivo, and re-examined effects on locomotor activity. PD144418 displayed high affinity for sigma1 sites (Ki 0.46 nM) and 3596-fold selectivity over sigma2 sites (Ki 1654 nM) in guinea pig brain membranes. No appreciable affinity was noted for serotonin and norepinephrine transporters (Ki >100 muM), and the DAT interaction was weak (Ki 9.0 muM). In vivo, PD144418 bound to central and peripheral sigma1 sites in mouse, with an ED50 of 0.22 mumol/kg in whole brain. No DAT occupancy by PD144418 (10.0 mumol/kg) or possible metabolites were observed. At doses that did not affect basal locomotor activity, PD144418 (1, 3.16, and 10 mumol/kg) attenuated cocaine-induced hyperactivity in a dose-dependent manner in mice. There was good correlation (r(2) = 0.88) of hyperactivity reduction with increasing cerebral sigma1 receptor occupancy. The behavioral ED50 of 0.79 mumol/kg corresponded to 80% occupancy. Significant sigma1 receptor occupancy and the ability to mitigate cocaine's motor stimulatory effects were observed for 16 hours after a single 10.0 mumol/kg dose of PD144418.
The pharmacology of the novel and selective sigma ligand, PD 144418.[Pubmed:9144641]
Neuropharmacology. 1997 Jan;36(1):51-62.
The pharmacology of PD 144418 (1-propyl-5-(3-p-tolyl-isoxazol-5-yl)-1,2,3,6-tetrahydropyridine) was characterized using neurochemical, biochemical and behavioral techniques. For sigma (sigma 1 and sigma 2 respectively) sites, PD 144418 affinities were determined using whole guinea pig brain membranes with [3H](+)-pentazocine and neuroblastoma x glioma cell membranes using [3H]1,3,di-O-tolylguanidine (DTG) in the presence of 200 nM (+)-pentazocine. PD 144418 exhibited an affinity for sigma 1 of 0.08 nM (Ki) versus a K1 of 1377 nM for sigma 2 site. Additional receptor binding studies indicated that PD 144418 lacked affinity for dopaminergic, adrenergic, muscarinic and a variety of other receptors. In vitro studies indicated that PD 144418 reversed the N-methyl-D-aspartate (NMDA)-induced increase in cyclic GMP (cGMP) in rat cerebellar slices without affecting the basal levels, suggesting that sigma 1 sites may be important in the regulation of glutamine-induced actions. PD 144418 potentiated the decrease in 5-hydroxytryptophan caused by haloperidol in the mesolimbic region, but by itself had no effect in 5-hydroxytrypamine (5-HT) and dopamine (DA) synthesis. Behaviorally, similar to other sigma ligands, PD 144418 antagonized mescaline-induced scratching at doses that did not alter spontaneous motor activity. This action is suggestive of potential antipsychotic property. It exhibited no anxiolytic and antidepressant properties in the models used. These results show that PD 144418 is a very selective sigma 1 agent, devoid of any significant affinity for other receptors and that sigma 1 site may modulate actions in the CNS.